Skip to main content

Peer Review reports

From: CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma

Original Submission
12 Nov 2019 Submitted Original manuscript
25 Jan 2020 Reviewed Reviewer Report - V. G. M. Naidu
17 Mar 2020 Reviewed Reviewer Report
21 May 2020 Author responded Author comments - Young Chang
Resubmission - Version 2
21 May 2020 Submitted Manuscript version 2
13 Jun 2020 Reviewed Reviewer Report
16 Sep 2020 Reviewed Reviewer Report - Research Square Reviewer 1
27 Sep 2020 Author responded Author comments - Young Chang
Resubmission - Version 3
27 Sep 2020 Submitted Manuscript version 3
Publishing
29 Sep 2020 Editorially accepted
15 Oct 2020 Article published 10.1186/s12885-020-07471-3

You can find further information about peer review here.

Back to article page